Skip to main content
. 2024 Jul 29;8(8):e106. doi: 10.1002/hem3.106

Figure 2.

Figure 2

Survival outcome after the second autologous stem‐cell transplantation (ASCT2) for all patients; (A) For Kaplan–Meier estimates for event‐free survival (EFS), median EFS was 2.6 years. (B) For Kaplan–Meier estimates for overall survival (OS), median OS was 8.1 years.